Innovations for Enhancing Glaucoma Care
Year: 2025
Type: editorial
Abstract: INTRODUCTION Glaucoma, a leading cause of irreversible blindness worldwide, demands continuous innovation to improve early detection, monitoring, and management. Traditional methods, while effective, face limitations in accessibility, patient adherence, and diagnostic efficiency. Recent technological advancements are reshaping the landscape of glaucoma care, offering promising solutions to longstanding challenges. Virtual reality (VR) perimetry is revolutionizing visual field testing by enhancing portability, patient comfort, and real-world applicability, potentially improving screening and follow-up compliance. Simultaneously, artificial intelligence (AI)-based automatic detection of glaucoma from fundus images is streamlining diagnosis, enabling faster and more objective assessment, even in resource-limited settings. Home monitoring tools, including intraocular pressure (IOP) evaluation and tracking, and remote visual field assessments, are empowering patients to actively participate in their care, facilitating earlier intervention and personalized management strategies. These innovations hold the potential to shift glaucoma care from a clinic-cantered to a more patient-centric model, bridging gaps in care delivery. However, challenges such as validation, regulatory approvals, integration into existing workflows, and cost-effectiveness must be addressed to ensure widespread adoption. This editorial explores the evolving landscape of glaucoma innovations and their present status. VIRTUAL REALITY PERIMETRY VR perimetry opens promising avenues for making visual field testing more accessible for screening, especially in outreach, and overcomes the limitations of traditional bulky instrumentation, as in standard automated perimetry. The BOLT strategy (better, optimized, less time) uses an advanced algorithm to predict responses and a suprathreshold strategy, which reduces testing time significantly.[1,2] The zippy estimation by sequential testing (ZEST) algorithm efficiently determines a patient’s visual field threshold by rapidly adjusting stimulus intensity based on their responses, essentially allowing for faster and more accurate visual field testing compared to traditional methods.[3] The C3 field analyzer uses a suprathreshold strategy where the stimuli presented are noticeably brighter than the patient’s visual threshold, thereby engaging the patients and helping in quick screening. This is essentially a pass/fail screening tool to identify potential visual field deficits, rather than precisely measuring the exact sensitivity at each point like a standard threshold test.[4,5]Table 1 summarizes the salient points of available testing modalities.Table 1: Literature review on virtual reality perimetersThough the available researches are carried out in small controlled groups, it is strong enough to show the potential of VR perimetry in glaucoma screening. By refining the available algorithms and testing in larger population in a longitudinal fashion, these perimeters can be explored further. With the available evidence, it is clear that VR perimetry has the potential to revolutionize glaucoma screening and detection, and this technology is here to stay. AUTOMATED DETECTION OF GLAUCOMA USING FUNDUS IMAGES Glaucoma is an asymptomatic disease, and often patients present at an advanced stage with severe irreversible visual impairment. Hence, it is crucial to detect and intervene at an early stage to preserve vision. The process of detecting glaucoma in its early stages is a very perplexing and lengthy process, requiring expert knowledge and multiple hospital visits. Optic nerve head changes can also be evaluated and detected by various imaging modalities such as fundus cameras and optical coherence tomography.[6] Fundus imaging of good quality by portable smartphone cameras is a cost-effective technique for screening purposes, such as in community outreach programs.[7] With the advent of AI, such fundus images are analyzed using automated algorithms. Glaucoma is one such condition where AI technology can be incorporated to detect in its early stages.[8] AI mainly uses two types of approaches for glaucoma detection from segmented images, namely, logical rule-based AI frameworks and machine learning/statistical modeling-based AI frameworks.[8] The process of screening is made simple by software algorithms so that picking up the condition can be done by persons with less expertise, making it an effective tool in telemedicine. With technological advancements, AI-enabled fundus imaging can help in the reduction of human error and aid in screening for the disease, prompt referral, and monitoring progression. In fact, a recent trial at vision centers reported that AI outperformed tele-ophthalmologists, showing an agreement of around 80% with the glaucoma specialist.[9]Table 2 discusses the papers on logical rule-based AI frameworks.Table 2: Papers proposing logical rule-based AI frameworks for automatic detection of glaucoma based on disc imagesHOME MONITORING OF GLAUCOMA Glaucoma needs a holistic approach, which includes monitoring of IOP and the structural and functional health of the optic nerve by means of optical coherence tomography, fundus photography, and visual field testing. Home monitoring of visual fields includes tab-based applications (visual field fast on Apple tab,[17] Eyecatcher[18] by the UK using the ZEST algorithm, visual fields easy, Melbourne, Australia, Melbourne rapid fields[19]); web-based perimeters (test vision software for android phones and desktops,[20] progression of patterns software,[21] damato multi-fixation campimetry online)[22]; and head-mounted perimeters (CFA, Gear vision, VisuALL).[5] These modalities of visual field evaluation show promising results of monitoring the progression effectively, with an acceptable range of sensitivity and specificity, but the major limitation remains the reliability indices of these tests. iCare HOME tonometry[23] has been approved by the USFDA for patient usage, and this has proven to be of immense benefit in closely monitoring IOP, while also helping to reassure patients about their IOP levels. Though the results from short-term studies are encouraging, the challenges of accuracy, providing assistance during troubleshooting, and technology concerns are the major hurdles that need to be addressed. Another most crucial aspect of home monitoring remains to be the fundus imaging. Though there are nonmydriatic fundus image capturing apps available, their clinical correlation remains questionable due to the inability to dilate. However, their application in teleophthalmology has been proven to be a game changer in detecting posterior segment pathologies. CONCLUSION Innovations in VR perimetry, AI-driven glaucoma detection, and home monitoring are transforming glaucoma care, enhancing accessibility and patient engagement. While challenges remain in validation and integration, these advancements pave the way for a more proactive, personalized approach, ultimately improving outcomes and reducing the burden of glaucoma-related blindness. However, we must wait for high-quality evidence before implementing these technologies. Additionally, adopting a community-based model, such as vision centers, could help reduce the costs associated with these emerging technologies.
Institution: Aravind Eye Hospital
Language: English
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4411784331